The heptapeptide (ATWLPPR) targeting the NRP-1 protein was also used in the study by Hu [59], in which this peptide was associated with CGKRK forming the dual-decorated nanoparticulate (designated AC-NP) to achieve a dual-targeting effect for angiogenic blood vessels and the tumor microenvironment. Here, NRP1 is linked to neoplasm.